Director Ilan Shiloah resigns from Silexion Therapeutics board effective Sept 16, 2024

Silexion Therapeutics Corp

Ilan Shiloah resigned as independent director and from audit, compensation, and governance committees.
Resignation effective September 16, 2024; cited competing time demands.
No disagreement with company operations, policies, or practices stated.
Shiloah served since business combination closing on August 15, 2024.
No replacement named at this time.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ilan Shiloah

independent director

SLXN · Silexion Therapeutics Corp

Effective: 2024-09-16
Filed: September 19, 2024, 7:59 PM ET

On September 16, 2024, Ilan Shiloah, an independent director serving on the board of directors (the “Board”) of Silexion Therapeutics Corp, a Cayman Islands exempted company (the “Company”), informed the Company that he has resigned from the Board, including from his membership on each of the committees of the Board— the audit committee, the compensation committee, and the corporate governance and nominating committee— effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ilan Shiloah resigned as independent director at Silexion Therapeutics Corp.

Action: resigned
Role: independent director

Exact text from the filing

On September 16, 2024, Ilan Shiloah, an independent director serving on the board of directors (the “Board”) of Silexion Therapeutics Corp, a Cayman Islands exempted company (the “Company”), informed the Company that he has resigned from the Board, including from his membership on each of the committees of the Board— the audit committee, the compensation committee, and the corporate governance and nominating committee— effective immediately.

View on SEC.gov

Silexion Therapeutics Corp filing history →

Source: SEC EDGAR

accession 0001213900-24-080268

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.